National Cancer Registry

Definition	A cancer registry is defined as a location, be it an office or institution, where collection, storage, analysis and interpretation of data on cancer patients take place (Jenson et al, 1991).
Objectives	- To measure cancer incidence - To describe cancer by time, place, persons and disease - To provide a national database for further epidemiological research
Case definition	Target cases are: - Incident cases by year of diagnosis - Malignant tumors confirmed by histopathology and/or hematology findings - Cancers of all sites
Sources of data	Data are collected through two main channels: the capture system (passive reporting) and the recapture system (active reporting). 1) The capture system: The capture system is based on physician’s routine reporting of cancer cases. Physician’s complete and send forms: - Directly from their clinic; or - Indirectly through the MOPH Drug Dispensing Center (DDC), where anti-cancer drugs are distributed to eligible patients 2) The recapture system: The recapture system is based on gathering information directly from histopathological and hematological laboratories. Data are collected in various ways, using hard or soft copies, or using database file or individual laboratory results depending on laboratories resources. This process is active since the NCR personnel actually contact the sites to obtain the necessary data. The recapture system validates and complements the capture approach.
Medical coding	The coding of cancer primary sites and cancer morphology is done using International Classification of Diseases for Oncology, third edition (ICD-O-3). The code includes information on the topography (primary site), the histology, the behavior and the grade of the tumor. The structure is C##.# M####/##, where: - C##.# specifies the primary site - M#### specifies the histology - /## specifies the behavior and the grade of the tumor
Reporting form	NCR reporting form

ATC	Name	B/G	Ingredients	Dosage	Form	Price
D10AD51	ERYLIK	G	Tretinoin - 0.025%, Erythromycin - 4%		Gel	378,964 L.L
D10AD51	RETINOMYCIN	G	Tretinoin - 0.025%, Erythromycin - 4%		Gel	662,962 L.L
D10AD51	CLINIDERM T	G	Tretinoin - 0.025%, Clindamycin (phosphate) - 1%		Gel	801,186 L.L
D10AD51	MEDCLINIDERM-T	G	Tretinoin - 0.025%, Clindamycin (phosphate) - 1%		Gel	801,186 L.L
D10AD51	CLINIDERM T	G	Tretinoin - 0.05%, Clindamycin (phosphate) - 1%		Gel	890,776 L.L
D10AD51	MEDCLINIDERM-T	G	Tretinoin - 0.05%, Clindamycin (phosphate) - 1%		Gel	890,776 L.L
D10AD53	EPIDUO	B	Adapalene - 0.1%, Benzoyl peroxide - 2.5%		Gel	2,088,331 L.L
D10AD53	EPIDUO FORTE	B	Adapalene - 0.3%, Benzoyl peroxide - 2.5%		Gel	2,201,214 L.L
D10AE01	BENZAC AC	G	Benzoyl peroxide - 10g/100g	10%	Gel	416,591 L.L
D10AE01	BENZAC AC	G	Benzoyl peroxide - 5g/100g	5%	Gel	388,370 L.L
D10AF01	MEDACIN T	G	Clindamycin (phosphate) - 10mg/ml	10mg/ml	Solution	314,459 L.L
D10AF01	CLINIDERM	G	Clindamycin (phosphate) - 1%	1%	Gel	712,876 L.L
D10AF02	ERYFLUID	B	Erythromycin base - 40mg/ml	4%	Lotion	486,471 L.L
D10AF02	ERYFLUID	B	Erythromycin base - 4%	4%	Lotion	486,471 L.L
D10AF02	MED-ERYTHROMYCIN 4%	G	Erythromycin - 40mg/ml	4%	Solution	235,492 L.L
D10AF02	ERYTHROMYCIN 1.5 %	G	Erythromycin - 15mg/ml	1.5 %	Solution	501,701 L.L
D10AF02	SPOTEX	G	Erythromycin - 4%	4%	Gel	854,684 L.L
D10AF05	NADIXA	G	Nadifloxacin - 1%	1%	Cream	850,652 L.L
D10AF05	NAXIDERM	G	Nadifloxacin - 1%	1%	Gel	826,783 L.L
D10AF51	DUAC ONCE DAILY	B	Clindamycin (phosphate) - 1%, Benzoyl peroxide - 5%		Gel	1,658,302 L.L
D10AX03	SKINOREN	B	Azelaic acid - 0.2g/g	0.2g/g	Cream	722,987 L.L
D10BA01	CURACNE	G	Isotretinoin - 10mg	10mg	Capsule, soft gelatin	970,254 L.L
D10BA01	CURACNE	G	Isotretinoin - 10mg	10mg	Capsule, soft gelatin	970,254 L.L
D10BA01	A-CNOTREN	G	Isotretinoin - 20mg	20mg	Capsule, soft gelatin	1,468,376 L.L
D10BA01	CONTRACNE ISOTRETINOINE	G	Isotretinoin - 20mg	20mg	Capsule, soft	1,521,230 L.L
D10BA01	CURACNE	G	Isotretinoin - 20mg	20mg	Capsule, soft gelatin	1,603,204 L.L
D10BA01	CURACNE	G	Isotretinoin - 20mg	20mg	Capsule, soft gelatin	1,603,204 L.L
D10BA01	CURACNE	G	Isotretinoin - 5mg	5mg	Capsule, soft gelatin	856,028 L.L
D10BA01	CURACNE	G	Isotretinoin - 5mg	5mg	Capsule, soft gelatin	856,028 L.L
D10BA01	ISOSUPRA LIDOSE	G	Isotretinoin - 16mg	16mg	Capsule, hard	1,826,282 L.L

National Cancer Registry (NCR)